Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

The landscape for compounded GLP-1s has indeed become more complex after the FDA's increased scrutiny and warning letters issued to some compounding pharmacies and providers. It's crucial to understand that the FDA's concern is primarily with compounding pharmacies creating identical copies of commercially available, FDA-approved drugs (like Ozempic, Wegovy, Mounjaro, Zepbound) without a specific clinical need for compounding, or using unapproved bulk drug substances. They are not banning all compounding, but emphasizing that it must adhere to specific legal and safety guidelines (e.g., patient-specific prescriptions, non-identical formulations, or during drug shortages).

Many telehealth services have either pivoted to focusing on FDA-approved medications or have carefully refined their partnerships with compounding pharmacies to ensure compliance.

Here are some telehealth services that have historically offered, or continue to offer, compounded GLP-1s, often emphasizing their partnerships with licensed 503A compounding pharmacies:

1. Henry Meds:

   • Why: Henry Meds has been one of the most prominent telehealth platforms offering compounded GLP-1 options (like semaglutide and tirzepatide). They frequently highlight their commitment to working with 503A compounding pharmacies, which are typically state-licensed and subject to state boards of pharmacy oversight. They aim to provide more affordable access to these medications.

2. Mochi Health:

   • Why: Mochi Health specializes in obesity treatment and often includes compounded GLP-1s as part of its personalized treatment plans, alongside lifestyle interventions. They also emphasize working with vetted compounding pharmacies.

3. IVIM Health:

   • Why: IVIM Health offers a comprehensive weight management program that can include compounded GLP-1s, among other medications, based on a patient's individual needs. They position themselves as providing medical supervision for these treatments.

4. Join Friday:

   • Why: A newer entrant, Join Friday has positioned itself as an affordable and accessible option for GLP-1 medications, often through compounded versions sourced from licensed pharmacies.

Important Considerations Before Choosing a Service:

• Consultation Required: All legitimate services will require a thorough medical consultation with a licensed healthcare provider to determine if compounded GLP-1s are appropriate for your specific health situation.
• Source of Compounded Medications: Ask about the specific compounding pharmacy they partner with. Legitimate services work with 503A compounding pharmacies (traditional pharmacies that compound based on individual patient prescriptions) that adhere to state and federal compounding regulations.
• Transparency: Ensure the service is transparent about the ingredients, sourcing, and any potential side effects of the compounded medication.
• Cost and Insurance: Compounded GLP-1s are typically not covered by insurance, and pricing can vary significantly between services.
• Safety and Efficacy: While compounded medications can be a viable option when FDA-approved versions are unavailable or unsuitable, they do not undergo the same rigorous clinical trials for safety and efficacy as FDA-approved drugs. Discuss all risks and benefits with your provider.
• Dynamic Landscape: The regulatory environment is constantly evolving. What is available today might change in the future.

Always prioritize your health and consult with a trusted medical professional to make informed decisions about any medication.